Cardiovascular disease is the leading cause of death worldwide. Hypertension, as one of the predisposing factors of cardiovascular disease, is an important reason for the high incidence of cardiovascular disease. Actively ...
Aug 5, 2024
0
0
If you enjoy a bowl of plain yogurt in the morning, adding a spoonful of honey is a delicious way to sweeten your favorite breakfast food. It also supports the probiotic cultures in the popular fermented dairy product, according ...
Aug 5, 2024
0
59
Mental health screenings must be incorporated into routine prostate cancer diagnoses say University of South Australia researchers. The call follows new research in Psycho-Oncology that shows men need more support both during ...
Aug 5, 2024
0
0
A new form of immunotherapy using innovative nanoparticles can delay resistance to hormone therapy and help men with prostate cancer live longer.
Aug 5, 2024
0
1
Montana is proposing wide-ranging rules for licensing abortion clinics under a disputed state law, raising a new potential obstacle for patients even as a constitutional amendment to protect access appears headed for the ...
Aug 5, 2024
0
0
In a new translational research study published in Cancer Research, investigators at Beth Israel Deaconess Medical Center (BIDMC) explored the potential of statins—commonly used medications for managing cholesterol levels—to ...
Aug 5, 2024
0
0
Wearable trackers and monitors (such as smartwatches) are increasingly popular and sophisticated. For people living with heart conditions, they can provide important information, including updates about abnormalities in heart ...
Aug 4, 2024
0
19
The Australian National Health and Medical Research Council (NHMRC) has just released its much-anticipated landmark statement advocating for sex, gender, variations of sex characteristics and sexual orientation to be routinely ...
Aug 4, 2024
0
0
The U.S. Food and Drug Administration has approved Leqselvi (deuruxolitinib) tablets for the treatment of adults with severe alopecia areata.
Aug 3, 2024
0
1
Scientists at St. Jude Children's Research Hospital have created a panel that is able to provide a diagnosis for more than 90% of pediatric cancer patients by sequencing 0.15% of the human genome. The panel is a cost-effective ...
Aug 2, 2024
0
0
